Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through two business areas: Respiratory & Acute Care and Obstructive Sleep Apnea. The Respiratory & Acute Care business offers a broad range of heated humidification products and systems which are used in the treatment of respiratory conditions by ventilation or oxygen therapy. Its products include respiratory humidifiers, single-use and reusable chambers and breathing circuits, infant resuscitators, infant warmers and accessories. The Obstructive Sleep Apnea business offers continuous positive airway pressure therapy products, which are used in the treatment of obstructive sleep apnea to prevent temporary airway closure during sleep. Fisher & Paykel Healthcare was founded in 1934 and is headquartered in Auckland, New Zealand.
Market Price at 20-11-2017
Price to Earnings Ratio
Return on Equity (ROE)
Blog posts that reference Fisher & Paykel Healthcare Corp:
It is a well known fact that Australians and New Zealanders have a rich history of gentle ribbing, but while the great debate about who makes the better Pavlova remains unresolved, Skaffold has found some common ground where we all agree and that is adding New Zealand stocks dual listed on the ASX into Skaffold. We have added 39 requested stocks into Skaffold (Australia).